<DOC>
	<DOCNO>NCT02802085</DOCNO>
	<brief_summary>Voluntary Post-Marketing Clinical Follow-up ( PMCF ) part post marketing surveillance plan product investigation . For PMCF CE-marked medical device use use within intend purpose additional invasive stressful examination carry ( acc . MPG §23b ) .</brief_summary>
	<brief_title>VEGA Prospective Kiel</brief_title>
	<detailed_description>This non-interventional clinical study ( NIS ) conduct clinically confirm safety performance Aesculap® VEGA System® PS component routine condition . The VEGA System® PS establish TKA design , long-lasting experience use PS component particular ; thus NIS think sufficient give require confirmation . For NIS CE-marked medical device use use within intend purpose additional invasive stressful examination carry ( acc . MPG §23b ) . This voluntary NIS part post-marketing surveillance product investigation .</detailed_description>
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<criteria>Patient receive primary TKA study site five six year ago use product investigation follow severe knee joint condition could treat therapy : degenerative osteoarthritis , rheumatoid arthritis , posttraumatic arthritis , symptomatic knee instability , knee stiffness deformation knee joint Age time surgery ≥ 18 year Patient sign informed consent Age young 18 year time surgery Any prior joint replacement index knee Patient sign inform consent All case list indication ( accord IfU ) All case show contraindication ( accord IfU )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>Total Knee Arthroplasty</keyword>
	<keyword>Total Knee Replacement</keyword>
	<keyword>TKA</keyword>
	<keyword>TKR</keyword>
	<keyword>Stiffness Knee</keyword>
	<keyword>Deformity</keyword>
	<keyword>Knee Joint</keyword>
	<keyword>Instability</keyword>
	<keyword>Post-traumatic</keyword>
	<keyword>Arthrosis</keyword>
</DOC>